Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of NT 3 Growth Factor Receptor market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of NT 3 Growth Factor Receptormarket, defines the market attractiveness level of NT 3 Growth Factor Receptor market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of NT 3 Growth Factor Receptor industry, describes the types of NT 3 Growth Factor Receptor market, the applications of major players and the market size, and deeply analyzes the current situation of the global NT 3 Growth Factor Receptor market and the development prospects and opportunities of NT 3 Growth Factor Receptor industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global NT 3 Growth Factor Receptor market in Chapter 13.
By Player:
Daiichi Sankyo Company Ltd
Array BioPharma Inc
Loxo Oncology Inc
Netris Pharma SAS
Handok Inc
AstraZeneca Plc
Ignyta Inc
Plexxikon Inc
By Type:
AZD-7451
Larotrectinib
DS-6051
LM-22B10
Others
By End-User:
Breast Cancer
Brain Cancer
Solid Tumor
Colon Cancer
Fibrosarcoma
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 NT 3 Growth Factor Receptor Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 NT 3 Growth Factor Receptor Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 NT 3 Growth Factor Receptor Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 NT 3 Growth Factor Receptor Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise NT 3 Growth Factor Receptor Market Analysis and Outlook to 2022
-
7.1 Global NT 3 Growth Factor Receptor Consumption (2017-2022)
-
7.2 United States NT 3 Growth Factor Receptor Consumption (2017-2022)
-
7.3 Europe NT 3 Growth Factor Receptor Consumption (2017-2022)
-
7.4 China NT 3 Growth Factor Receptor Consumption (2017-2022)
-
7.5 Japan NT 3 Growth Factor Receptor Consumption (2017-2022)
-
7.6 India NT 3 Growth Factor Receptor Consumption (2017-2022)
-
7.7 South Korea NT 3 Growth Factor Receptor Consumption (2017-2022)
8 Region and Country-wise NT 3 Growth Factor Receptor Market Analysis and Outlook to 2028
-
8.1 Global NT 3 Growth Factor Receptor Consumption Forecast (2022-2028)
-
8.2 United States NT 3 Growth Factor Receptor Consumption Forecast (2022-2028)
-
8.3 Europe NT 3 Growth Factor Receptor Consumption Forecast (2022-2028)
-
8.4 China NT 3 Growth Factor Receptor Consumption Forecast (2022-2028)
-
8.5 Japan NT 3 Growth Factor Receptor Consumption Forecast (2022-2028)
-
8.6 India NT 3 Growth Factor Receptor Consumption Forecast (2022-2028)
-
8.7 South Korea NT 3 Growth Factor Receptor Consumption Forecast (2022-2028)
9 Global NT 3 Growth Factor Receptor Market Outlook by Types and Applications to 2022
-
9.1 Global NT 3 Growth Factor Receptor Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global AZD-7451 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Larotrectinib Consumption and Growth Rate (2017-2022)
-
9.1.3 Global DS-6051 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global LM-22B10 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global NT 3 Growth Factor Receptor Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Brain Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Solid Tumor Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Colon Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Fibrosarcoma Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Others Consumption and Growth Rate (2017-2022)
10 Global NT 3 Growth Factor Receptor Market Outlook by Types and Applications to 2028
-
10.1 Global NT 3 Growth Factor Receptor Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global AZD-7451 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Larotrectinib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global DS-6051 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global LM-22B10 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global NT 3 Growth Factor Receptor Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Brain Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Solid Tumor Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Colon Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Fibrosarcoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global NT 3 Growth Factor Receptor Import and Export Analysis (Top 5 Countries)
-
11.1 Global NT 3 Growth Factor Receptor Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global NT 3 Growth Factor Receptor Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 NT 3 Growth Factor Receptor Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global NT 3 Growth Factor Receptor Market Competitive Analysis
-
14.1 Daiichi Sankyo Company Ltd
-
14.1.1 Daiichi Sankyo Company Ltd Company Details
-
14.1.2 Daiichi Sankyo Company Ltd NT 3 Growth Factor Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Daiichi Sankyo Company Ltd NT 3 Growth Factor Receptor Product and Service
-
14.2 Array BioPharma Inc
-
14.2.1 Array BioPharma Inc Company Details
-
14.2.2 Array BioPharma Inc NT 3 Growth Factor Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Array BioPharma Inc NT 3 Growth Factor Receptor Product and Service
-
14.3 Loxo Oncology Inc
-
14.3.1 Loxo Oncology Inc Company Details
-
14.3.2 Loxo Oncology Inc NT 3 Growth Factor Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Loxo Oncology Inc NT 3 Growth Factor Receptor Product and Service
-
14.4 Netris Pharma SAS
-
14.4.1 Netris Pharma SAS Company Details
-
14.4.2 Netris Pharma SAS NT 3 Growth Factor Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Netris Pharma SAS NT 3 Growth Factor Receptor Product and Service
-
14.5 Handok Inc
-
14.5.1 Handok Inc Company Details
-
14.5.2 Handok Inc NT 3 Growth Factor Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Handok Inc NT 3 Growth Factor Receptor Product and Service
-
14.6 AstraZeneca Plc
-
14.6.1 AstraZeneca Plc Company Details
-
14.6.2 AstraZeneca Plc NT 3 Growth Factor Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 AstraZeneca Plc NT 3 Growth Factor Receptor Product and Service
-
14.7 Ignyta Inc
-
14.7.1 Ignyta Inc Company Details
-
14.7.2 Ignyta Inc NT 3 Growth Factor Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Ignyta Inc NT 3 Growth Factor Receptor Product and Service
-
14.8 Plexxikon Inc
-
14.8.1 Plexxikon Inc Company Details
-
14.8.2 Plexxikon Inc NT 3 Growth Factor Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Plexxikon Inc NT 3 Growth Factor Receptor Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of NT 3 Growth Factor Receptor
-
Figure NT 3 Growth Factor Receptor Picture
-
Table Global NT 3 Growth Factor Receptor Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global NT 3 Growth Factor Receptor Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global NT 3 Growth Factor Receptor Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global NT 3 Growth Factor Receptor Consumption by Country (2017-2022)
-
Figure United States NT 3 Growth Factor Receptor Consumption and Growth Rate (2017-2022)
-
Table Europe NT 3 Growth Factor Receptor Consumption and Growth Rate (2017-2022)
-
Figure China NT 3 Growth Factor Receptor Consumption and Growth Rate (2017-2022)
-
Figure Japan NT 3 Growth Factor Receptor Consumption and Growth Rate (2017-2022)
-
Figure India NT 3 Growth Factor Receptor Consumption and Growth Rate (2017-2022)
-
Figure South Korea NT 3 Growth Factor Receptor Consumption and Growth Rate (2017-2022)
-
Figure Global NT 3 Growth Factor Receptor Consumption Forecast by Country (2022-2028)
-
Figure United States NT 3 Growth Factor Receptor Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe NT 3 Growth Factor Receptor Consumption Forecast and Growth Rate (2022-2028)
-
Figure China NT 3 Growth Factor Receptor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan NT 3 Growth Factor Receptor Consumption Forecast and Growth Rate (2022-2028)
-
Figure India NT 3 Growth Factor Receptor Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea NT 3 Growth Factor Receptor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AZD-7451 Consumption and Growth Rate (2017-2022)
-
Figure Global Larotrectinib Consumption and Growth Rate (2017-2022)
-
Figure Global DS-6051 Consumption and Growth Rate (2017-2022)
-
Figure Global LM-22B10 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Brain Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Solid Tumor Consumption and Growth Rate (2017-2022)
-
Figure Global Colon Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Fibrosarcoma Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global AZD-7451 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Larotrectinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global DS-6051 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global LM-22B10 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Brain Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Solid Tumor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Colon Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Fibrosarcoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global NT 3 Growth Factor Receptor Import by Region (Top 5 Countries) (2017-2028)
-
Table Global NT 3 Growth Factor Receptor Export by Region (Top 5 Countries) (2017-2028)
-
Table Daiichi Sankyo Company Ltd (Foundation Year, Company Profile and etc.)
-
Table Daiichi Sankyo Company Ltd NT 3 Growth Factor Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Company Ltd NT 3 Growth Factor Receptor Product and Service
-
Table Array BioPharma Inc (Foundation Year, Company Profile and etc.)
-
Table Array BioPharma Inc NT 3 Growth Factor Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Array BioPharma Inc NT 3 Growth Factor Receptor Product and Service
-
Table Loxo Oncology Inc (Foundation Year, Company Profile and etc.)
-
Table Loxo Oncology Inc NT 3 Growth Factor Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Loxo Oncology Inc NT 3 Growth Factor Receptor Product and Service
-
Table Netris Pharma SAS (Foundation Year, Company Profile and etc.)
-
Table Netris Pharma SAS NT 3 Growth Factor Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Netris Pharma SAS NT 3 Growth Factor Receptor Product and Service
-
Table Handok Inc (Foundation Year, Company Profile and etc.)
-
Table Handok Inc NT 3 Growth Factor Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Handok Inc NT 3 Growth Factor Receptor Product and Service
-
Table AstraZeneca Plc (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Plc NT 3 Growth Factor Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Plc NT 3 Growth Factor Receptor Product and Service
-
Table Ignyta Inc (Foundation Year, Company Profile and etc.)
-
Table Ignyta Inc NT 3 Growth Factor Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ignyta Inc NT 3 Growth Factor Receptor Product and Service
-
Table Plexxikon Inc (Foundation Year, Company Profile and etc.)
-
Table Plexxikon Inc NT 3 Growth Factor Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Plexxikon Inc NT 3 Growth Factor Receptor Product and Service
-
